Remetinostat, also known as SHP-141, is a topical formulation containing the histone deacetylase (HDAC) inhibitor with potential antineoplastic activity.
For research use only. We do not sell to patients.
Name | Remetinostat |
---|---|
Iupac Chemical Name | methyl 4-((8-(hydroxyamino)-8-oxooctanoyl)oxy)benzoate |
Synonyms | Remetinostat; SHP-141; SHP-141; SHP-141; SHAPE |
Molecular Formula | C16H21NO6 |
Molecular Weight | 323.345 |
Smile | O=C(OC)C1=CC=C(OC(CCCCCCC(NO)=O)=O)C=C1 |
InChiKey | XDZAHHULFQIBFE-UHFFFAOYSA-N |
InChi | InChI=1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18) |
CAS Number | 946150-57-8 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |